stockrow
Friday 6 November 2026
Export ACON’s income statement to Excel — free account
Aclarion, Inc.
ACON Healthcare Health Information Services
Aclarion, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75,700.00, up 65.6% from fiscal 2024.
- Revenue
- +78.5%
- EPS
- +67.9%
- Free cash flow
- −74.2%
Quarter to September 2026, against a year earlier
1.66
0.10
+6.41%
Follow ACON
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 4 | 4 | 4 |
| (104.89%) | (45.43%) | (58.97%) | (74.07%) | ||
| (91.67%) | (43.37%) | (56.09%) | (69.66%) | ||
ROIC |
(554.92%) | (855.42%) | (876.79%) | (1,120.88%) | |
Return on Tangible Assets |
(62.50%) | (43.72%) | (58.28%) | (74.51%) | |
Average Days of Receivables |
143.20 | 190.48 | 122.97 | 123.14 | |
Free Cash Flow per Share |
(13.86) | (3.50) | (3.36) | (3.29) | |
Free Cash Flow |
(7.37) | (7.45) | (8.26) | (9.14) | |
Capital Expenditures |
(0.21) | (0.15) | (0.17) | (0.19) | |
| Other line items | |||||
Cash ROIC |
(29.64%) | (19.25%) | (24.80%) | (31.49%) | |
Accounts Receivable Turnover |
3.15 | 2.60 | 3.41 | 3.02 | |
Accounts Payable Turnover |
0.16 | 0.11 | 0.13 | 0.27 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
1,761.52 | 3,408.02 | 3,922.64 | 1,234.85 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
1,365.52% | 1,479.31% | 1,406.93% | 1,265.68% | |
Selling, General and Administrative Expense of Revenue |
7,959.58% | 9,526.35% | 10,216.49% | 9,555.56% | |
Share Based Compensation of Revenue |
139.23% | 69.67% | 152.81% | 544.00% | |
Operating CF/Net income |
0.99 | 0.91 | 0.88 | 0.88 | |
Depreciation/Fixed assets |
9.40 | 10.18 | 10.45 | 0.00 | |
Capex/Depreciation |
(0.92) | (0.66) | (0.72) | 0.00 | |
Revenue per Share |
0.14 | 0.04 | 0.03 | 0.04 | |
Operating CF per Share |
(13.47) | (3.43) | (3.28) | (3.22) | |
Capex per Share |
(0.39) | (0.07) | (0.07) | (0.07) | |
Capex to Sales |
2.76 | 1.97 | 2.09 | 1.94 |
Columns are period end dates · fundamentals updated 5 Nov 2026